Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026. Infectious Diseases – Infektsiyni khvoroby, n. 3, p. 13–26, 30 Sep.2026.